FDA Adverse Event Injury Summary report: N

ACL TOP CTS

MDR report key: 6880325 · Received September 20, 2017

Report

Report Number
1217183-2017-00004
Event Type
Injury
Date Received
September 20, 2017
Date of Event
August 22, 2017
Report Date
September 20, 2017
Manufacturer
INSTRUMENTATION LABORATORY
Product Code
GKP
PMA / PMN Number
K073377
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

AN INVESTIGATION WAS CONDUCTED THAT INCLUDED A REVIEW OF THE INSTRUMENT DATA. REVIEW OF THE DATA CONCLUDED THAT THE VALUES OBTAINED ON THE ACL TOP WERE APPROPRIATELY DETERMINED BY THE ANALYZER AND THE INSTRUMENT WAS PERFORMING AS INTENDED. WHILE THE ROOT CASE CANNOT BE DETERMINED, THERE ARE MANY VARIABLES THAT HAVE THE POTENTIAL TO INFLUENCE THE RESULT RECOVERIES. THESE MAY INCLUDE, BUT NOT LIMITED TO, THE ACCURACY OF THE RECONSTITUTION OF THE REAGENTS AND CLEANING MATERIALS USED, THE ONBOARD STABILITY OF MATERIALS USED, REAGENT AND/OR SAMPLE HANDLING, AND SAMPLE INTEGRITY ALL OF WHICH COULD HAVE CONTRIBUTED TO THE GENERATED FINDINGS. BASED ON THE ABOVE, THERE WAS NO INDICATION OF AN INSTRUMENT MALFUNCTION AND NO REMEDIAL ACTION IS NEEDED.

Description of Event or Problem · 1

CUSTOMER REPORTED THAT THEIR ACL TOP CTS REPORTED ERRONEOUS APTT PATIENT RESULTS USING HEMOSIL SYNTHASIL. THIRTEEN SAMPLES GENERATED ERRONEOUS RESULTS. ONE PATIENT WAS ADMINISTERED AN UNNECESSARY BOLUS OF HEPARIN DUE TO THE APTT RESULT BEING LOWER THAN EXPECTED. ALL THIRTEEN SAMPLES WERE SUBSEQUENTLY CORRECTED AND THERE WERE NO REPORTED SERIOUS ADVERSE EVENTS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
659373 ACL TOP CTS ACL TOP GKP INSTRUMENTATION LABORATORY 2800-20

Patients

Seq Age Sex Outcome Treatment
1 Other